-transparent.png){kind=logo}
Most sera from patients with rheumatoid arthritis as well as some sera from normal Epstein-Barr virus (EBV)-infected people detect a 140-kDa protein on immunoblots of EBV-infected lymphoblasts. The 140-kDa protein is a nuclear protein characteristic of latent EBV infection. Sera reactive with this protein identify a distinctive globular nuclear antigen. Although the 140-kDa protein is encoded by EBV, it is not encoded by genes that encode the two previously described EBV nuclear antigens (EBNA) or the latent-infection membrane protein. The 140-kDa protein is therefore designated EBNA3. The EBV genes, including the gene encoding EBNA3, that are characteristically expressed in latent infection are likely to play a role in the maintenance of persistent latent viral infection or in the cell proliferation caused by virus infection.
K Hennessy, and
S Fennewald, and
E Kieff
July 1994,
Blood,
K Hennessy, and
S Fennewald, and
E Kieff
May 1984,
The Journal of experimental medicine,
K Hennessy, and
S Fennewald, and
E Kieff
July 2006,
CSH protocols,
K Hennessy, and
S Fennewald, and
E Kieff
December 1977,
Lancet (London, England),
K Hennessy, and
S Fennewald, and
E Kieff
January 1990,
American journal of otolaryngology,
K Hennessy, and
S Fennewald, and
E Kieff
March 1985,
Science (New York, N.Y.),
K Hennessy, and
S Fennewald, and
E Kieff
November 1986,
Molecular and cellular biology,
K Hennessy, and
S Fennewald, and
E Kieff
January 1982,
Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale,
K Hennessy, and
S Fennewald, and
E Kieff
September 2008,
Journal of virology,
K Hennessy, and
S Fennewald, and
E Kieff
April 2006,
The Journal of general virology,
